GeneFerm Biotechnology Co. Ltd.(TW:1796)
NT$28.00+0.45 (+1.63%)
TW:1796
GeneFerm Biotechnology Co. Ltd. Revenue
NT$28.00
At close:+0.45 (+1.63%)
GeneFerm Biotechnology Co. Ltd. (1796) Revenue
GeneFerm Biotechnology Co. Ltd. Revenue
GeneFerm Biotechnology Co. Ltd. had a revenue of 168.93M in the quarter ending Jun 30, 2026, with 10.27%. This bring the company's revenue in the last twelve months to 664.93M, Increased 0.16%. In the fiscal year ending Dec 31, 2025, GeneFerm Biotechnology Co. Ltd. had annual revenue of 677.10M with 29.92% growth.
- Revenue (ttm)
- 664.93M
- Revenue Growth
- 7.05%
- P/S Ratio
- 1.69
- Revenue/Employee
- TWD 2,351,035
- Employees
- 288
- Market Cap
- TWD 1.14B
Revenue Chart
GeneFerm Biotechnology Co. Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 677.10M | 155.94M | 29.92% |
| Dec 31, 2024 | 521.16M | -272.61M | -34.34% |
| Dec 31, 2023 | 793.77M | 159.81M | 25.21% |
| Dec 31, 2022 | 633.96M | 111.63M | 21.37% |
| Dec 31, 2021 | 522.33M | 154.03M | 41.82% |
| Dec 31, 2020 | 368.30M | 40.07M | 12.21% |
| Dec 31, 2019 | 328.23M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.